Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.

Very low density lipoproteins (VLDL) are produced in the liver and contain apolipoprotein (apo) B-100 and endogenous lipids. By contrast, ingestion of fat leads to formation of chylomicrons containing apoB-48 secreted from the intestine. In this study, a 60-min intravenous infusion of a chylomicron-...

Full description

Bibliographic Details
Main Authors: J Bjorkegren, C J Packard, A Hamsten, D Bedford, M Caslake, L Foster, J Shepherd, P Stewart, F Karpe
Format: Article
Language:English
Published: Elsevier 1996-01-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520376379
id doaj-ead82470dc3040639c8e20b1e3f48fb1
record_format Article
spelling doaj-ead82470dc3040639c8e20b1e3f48fb12021-04-26T05:49:09ZengElsevierJournal of Lipid Research0022-22751996-01-013717686Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.J Bjorkegren0C J Packard1A Hamsten2D Bedford3M Caslake4L Foster5J Shepherd6P Stewart7F Karpe8King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.Very low density lipoproteins (VLDL) are produced in the liver and contain apolipoprotein (apo) B-100 and endogenous lipids. By contrast, ingestion of fat leads to formation of chylomicrons containing apoB-48 secreted from the intestine. In this study, a 60-min intravenous infusion of a chylomicron-like triglyceride emulsion was given to healthy young men to examine whether competition between chylomicrons and VLDL for the same lipolytic pathway explains the increase in VLDL seen after meals. The responses of two major VLDL subfractions were determined by measuring the concentrations of apoB-100 in fractions of triglyceride-rich lipoproteins with Svedberg flotation rates of 60-400 (large VLDL) and 20-60 (small VLDL) that were separated from plasma by density gradient ultracentrifugation. A threefold elevation in plasma triglycerides was observed during the infusion together with a consistent linear increase of large VLDL. The rate at which large VLDL accumulated in plasma differed markedly among individuals and was not enhanced by doubling of the infusion rate. The response of small VLDL was more heterogeneous; however, a decrease was seen in most subjects. The combined pattern for the two VLDL species is what would be expected if large VLDL particles are the precursors of smaller VLDL species and if lipolysis of large VLDL is inhibited through competition from the triglyceride emulsion. The extent to which the triglyceride emulsion inhibited the lipolysis of VLDL and/or influenced the synthesis rate of large VLDL was estimated from simultaneous stable isotope studies. The emulsion caused a 75-90% block of the conversion of large VLDL apoB to small VLDL apoB and there was no sign of enhanced synthesis of large VLDL after infusion of the triglyceride emulsion. The corollary of these findings is that chylomicrons and their remnants impede the normal lipolytic degradation of VLDL and could thereby be indirectly implicated in the generation of atherogenic remnant lipoproteins.http://www.sciencedirect.com/science/article/pii/S0022227520376379
collection DOAJ
language English
format Article
sources DOAJ
author J Bjorkegren
C J Packard
A Hamsten
D Bedford
M Caslake
L Foster
J Shepherd
P Stewart
F Karpe
spellingShingle J Bjorkegren
C J Packard
A Hamsten
D Bedford
M Caslake
L Foster
J Shepherd
P Stewart
F Karpe
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Journal of Lipid Research
author_facet J Bjorkegren
C J Packard
A Hamsten
D Bedford
M Caslake
L Foster
J Shepherd
P Stewart
F Karpe
author_sort J Bjorkegren
title Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
title_short Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
title_full Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
title_fullStr Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
title_full_unstemmed Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
title_sort accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1996-01-01
description Very low density lipoproteins (VLDL) are produced in the liver and contain apolipoprotein (apo) B-100 and endogenous lipids. By contrast, ingestion of fat leads to formation of chylomicrons containing apoB-48 secreted from the intestine. In this study, a 60-min intravenous infusion of a chylomicron-like triglyceride emulsion was given to healthy young men to examine whether competition between chylomicrons and VLDL for the same lipolytic pathway explains the increase in VLDL seen after meals. The responses of two major VLDL subfractions were determined by measuring the concentrations of apoB-100 in fractions of triglyceride-rich lipoproteins with Svedberg flotation rates of 60-400 (large VLDL) and 20-60 (small VLDL) that were separated from plasma by density gradient ultracentrifugation. A threefold elevation in plasma triglycerides was observed during the infusion together with a consistent linear increase of large VLDL. The rate at which large VLDL accumulated in plasma differed markedly among individuals and was not enhanced by doubling of the infusion rate. The response of small VLDL was more heterogeneous; however, a decrease was seen in most subjects. The combined pattern for the two VLDL species is what would be expected if large VLDL particles are the precursors of smaller VLDL species and if lipolysis of large VLDL is inhibited through competition from the triglyceride emulsion. The extent to which the triglyceride emulsion inhibited the lipolysis of VLDL and/or influenced the synthesis rate of large VLDL was estimated from simultaneous stable isotope studies. The emulsion caused a 75-90% block of the conversion of large VLDL apoB to small VLDL apoB and there was no sign of enhanced synthesis of large VLDL after infusion of the triglyceride emulsion. The corollary of these findings is that chylomicrons and their remnants impede the normal lipolytic degradation of VLDL and could thereby be indirectly implicated in the generation of atherogenic remnant lipoproteins.
url http://www.sciencedirect.com/science/article/pii/S0022227520376379
work_keys_str_mv AT jbjorkegren accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT cjpackard accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT ahamsten accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT dbedford accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT mcaslake accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT lfoster accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT jshepherd accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT pstewart accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
AT fkarpe accumulationoflargeverylowdensitylipoproteininplasmaduringintravenousinfusionofachylomicronliketriglycerideemulsionreflectscompetitionforacommonlipolyticpathway
_version_ 1721508606033002496